144 related articles for article (PubMed ID: 15302308)
21. Selective estrogen receptor modulator and selective progesterone receptor modulator: therapeutic efficacy in the treatment of uterine leiomyoma.
Ohara N
Clin Exp Obstet Gynecol; 2005; 32(1):9-11. PubMed ID: 15864926
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
Morris EP; Rymer J; Robinson J; Fogelman I
Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
[TBL] [Abstract][Full Text] [Related]
23. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
[TBL] [Abstract][Full Text] [Related]
24. Current and Emerging Medical Treatments for Uterine Fibroids.
Chwalisz K; Taylor H
Semin Reprod Med; 2017 Nov; 35(6):510-522. PubMed ID: 29100239
[No Abstract] [Full Text] [Related]
25. Hemodynamic effect of danazol therapy in women with uterine leiomyomata.
La Marca A; Musacchio MC; Morgante G; Petraglia F; De Leo V
Fertil Steril; 2003 May; 79(5):1240-2. PubMed ID: 12738528
[No Abstract] [Full Text] [Related]
26. Benign breast disease.
Mauvais-Jarvis P; Kuttenn F
Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
[No Abstract] [Full Text] [Related]
27. Progestins and uterine leiomyoma.
Schweppe KW
Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():21-4. PubMed ID: 12227898
[TBL] [Abstract][Full Text] [Related]
28. [Gonadotropin-releasing hormone analogs].
Krysiak R; Okopień B; Herman ZS
Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
[TBL] [Abstract][Full Text] [Related]
29. Effects of gonadotropin-releasing hormone agonists on leiomyomas.
Mesia AF; Popiolek D
Arch Pathol Lab Med; 1999 Apr; 123(4):282-3. PubMed ID: 10320136
[No Abstract] [Full Text] [Related]
30. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
31. [Uterine leiomyoma].
Maruyama T; Asada H; Ono M; Arase T; Yoshimura Y
Nihon Rinsho; 2006 Jun; Suppl 2():477-84. PubMed ID: 16817446
[No Abstract] [Full Text] [Related]
32. Fibroids (uterine myomatosis, leiomyomas).
Lethaby A; Vollenhoven B
Clin Evid; 2004 Dec; (12):2563-85. PubMed ID: 15865807
[No Abstract] [Full Text] [Related]
33. [Possibilities of hormonal treatment of endometrial carcinoma].
Kopecný J; Rejthar A
Cesk Gynekol; 1990 Jul; 55(6):447-51. PubMed ID: 2208320
[No Abstract] [Full Text] [Related]
34. Medical management of fibroids.
Sankaran S; Manyonda IT
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
[TBL] [Abstract][Full Text] [Related]
35. [Drug treatments for uterine fibroma: rationale].
Fernandez H; Azoulay C; Rostoker G;
J Gynecol Obstet Biol Reprod (Paris); 2005 Jun; 34(4):360-405. PubMed ID: 16136663
[No Abstract] [Full Text] [Related]
36. Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro.
Liu J; Matsuo H; Xu Q; Chen W; Wang J; Maruo T
Hum Reprod; 2007 May; 22(5):1253-9. PubMed ID: 17220163
[TBL] [Abstract][Full Text] [Related]
37. Red degeneration of a uterine fibroid following the administration of gonadotropin releasing hormone agonists.
Hachiya K; Kato H; Kawaguchi S; Kojima T; Nishikawa Y; Fujiwara S; Matsuo M
J Obstet Gynaecol; 2016 Nov; 36(8):1018-1019. PubMed ID: 27750451
[No Abstract] [Full Text] [Related]
38. Induced hypoestrogenism increases the arterial resistance index of leiomyomata without affecting uterine or carotid arteries.
Spong CY; Sinow R; Renslo R; Cabus E; Rutgers J; Kletzky OA
J Assist Reprod Genet; 1995 May; 12(5):338-41. PubMed ID: 8520200
[No Abstract] [Full Text] [Related]
39. Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes.
De Falco M; Staibano S; Mascolo M; Mignogna C; Improda L; Ciociola F; Carbone IF; Di Lieto A
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):44-7. PubMed ID: 19297072
[TBL] [Abstract][Full Text] [Related]
40. [GnRH analogues and myomas: somewhat for].
Bats AS; Madelenat P
Gynecol Obstet Fertil; 2005 Dec; 33(12):1023-7. PubMed ID: 16316773
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
